Cilofexor
- Generic Name
- Cilofexor
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H22Cl3N3O5
- CAS Number
- 1418274-28-8
- Unique Ingredient Identifier
- YUN2306954
- Background
Cilofexor is under investigation in clinical trial NCT02943447 (Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis).
- Associated Conditions
- -
- Associated Therapies
- -
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Phase 2
Completed
- Conditions
- Nonalcoholic Steatohepatitis
- Interventions
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 457
- Registration Number
- NCT04971785
- Locations
- 🇺🇸
Charter Research, Winter Park, Florida, United States
🇺🇸Mercy Medical Center, Baltimore, Maryland, United States
🇺🇸Rush University Medical Group - Department of Hepatology, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath